stockportfolio.pro
Amphastar Pharmaceuticals, Inc. Total Debt 2012–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $619.71M | +1.0% |
| FY 2024 | $613.53M | +1.7% |
| FY 2023 | $603.17M | +687.0% |
| FY 2022 | $76.64M | -2.0% |
| FY 2021 | $78.19M | +70.3% |
| FY 2020 | $45.92M | -0.9% |
| FY 2019 | $46.32M | -5.6% |
| FY 2018 | $49.10M | +7.4% |
| FY 2017 | $45.72M | +26.9% |
| FY 2016 | $36.03M | -10.6% |
| FY 2015 | $40.30M | -5.6% |
| FY 2014 | $42.68M | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
Source: Amphastar Pharmaceuticals, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Amphastar Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmphastar Pharmaceuticals, Inc. — frequently asked questions
What is Amphastar Pharmaceuticals, Inc.'s total debt (short- plus long-term borrowings)?
Amphastar Pharmaceuticals, Inc. (AMPH) reported total debt (short- plus long-term borrowings) of $619.71M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Amphastar Pharmaceuticals, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.